| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-185-10 | 25021-185 | HUMAN PRESCRIPTION DRUG | ganciclovir | ganciclovir sodium | INJECTION, SOLUTION | INTRAVENOUS | 20180215 | N/A | ANDA | ANDA207645 | Sagent Pharmaceuticals | GANCICLOVIR SODIUM | 50 mg/mL | 25 VIAL in 1 CARTON (25021-185-10) / 10 mL in 1 VIAL |
| 51817-171-02 | 51817-171 | HUMAN PRESCRIPTION DRUG | Ganciclovir | ganciclovir sodium | INJECTION, SOLUTION | INTRAVENOUS | 20191215 | N/A | ANDA | ANDA207645 | Pharmascience Inc. | GANCICLOVIR SODIUM | 500 mg/10mL | 1 VIAL in 1 CARTON (51817-171-02) / 10 mL in 1 VIAL |
| 51817-171-01 | 51817-171 | HUMAN PRESCRIPTION DRUG | Ganciclovir | ganciclovir sodium | INJECTION, SOLUTION | INTRAVENOUS | 20180424 | N/A | ANDA | ANDA207645 | Pharmascience Inc. | GANCICLOVIR SODIUM | 500 mg/10mL | 25 VIAL in 1 CARTON (51817-171-01) / 10 mL in 1 VIAL |